Tipping Point: Tariffs Create Uncertainty, Risk Long-Term Price Increases, Shortages

 
• By Sue Sutter
  
Egg on table edge
The 10% tariff on API from China, if it lasts, could push some generic drug manufacturers out of some markets. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Distribution/Supply Chain

More from Biosimilars & Generics